Cargando…

Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature

AIMS: Immunomodulation in heart failure (HF) has been studied in several randomized controlled trials (RCTs) with variable effects on cardiac structure, function, and outcomes. We sought to determine the effect of immunomodulation on left ventricular ejection fraction (LVEF), LV end‐diastolic dimens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Navkaranbir S., Gupta, Kartik, Gharpure, Nitin, Pate, Mike, Chopra, Lakshay, Kalra, Rajat, Prabhu, Sumanth D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261557/ https://www.ncbi.nlm.nih.gov/pubmed/32198851 http://dx.doi.org/10.1002/ehf2.12681

Ejemplares similares

Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas
por: Bajaj, Navkaranbir S., et al.
Publicado: (2020)

Sleep duration, baseline cardiovascular risk, inflammation and incident cardiovascular mortality in ambulatory U.S. Adults: National health and nutrition examination survey
por: Gupta, Kartik, et al.
Publicado: (2021)

Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials
por: Gupta, Kartik, et al.
Publicado: (2020)

Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure
por: Patel, Bindiya, et al.
Publicado: (2017)

Cardiac Mesenchymal Stem Cells Promote Fibrosis and Remodeling in Heart Failure: Role of PDGF Signaling
por: Hamid, Tariq, et al.
Publicado: (2022)

The Role of Immunomodulation in Vein Graft Remodeling and Failure
por: Baganha, Fabiana, et al.
Publicado: (2020)

Hospitalization Rates, Prevalence of Cardiovascular Manifestations, and Outcomes Associated With Sarcoidosis in the United States
por: Patel, Nirav, et al.
Publicado: (2018)

Regional impact of updated guidelines on prevalence and distribution of blood pressure categories for hypertension in India: Results from the National Family Health Survey 4
por: Gupta, Kartik, et al.
Publicado: (2021)

Editorial: Inflammation and immunomodulation in cardiovascular remodeling
por: Ewing, Mark, et al.
Publicado: (2022)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Tracing triggers of cardiac remodelling and heart failure
por: van Driel, B. O., et al.
Publicado: (2021)

Comparison of Approaches to Revascularization in Patients With Multivessel Coronary Artery Disease Presenting With ST‐Segment Elevation Myocardial Infarction: Meta‐analyses of Randomized Control Trials
por: Bajaj, Navkaranbir S., et al.
Publicado: (2015)

Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis
por: Bajaj, Navkaranbir S., et al.
Publicado: (2019)

CCR2(+) Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload
por: Patel, Bindiya, et al.
Publicado: (2018)

Impact of medical therapy for cardiovascular disease on left ventricular diastolic properties and remodeling()()
por: Sharifov, Oleg F., et al.
Publicado: (2019)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Autonomic dysfunction is associated with cardiac remodelling in heart failure patients
por: Ali, Amna, et al.
Publicado: (2017)

Metabolomic signatures of cardiac remodelling and heart failure risk in the community
por: Andersson, Charlotte, et al.
Publicado: (2020)

PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling
por: Oppedisano, Francesca, et al.
Publicado: (2021)

GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure
por: Laudette, Marion, et al.
Publicado: (2021)

Cardiac remodelling predicts outcome in patients with chronic heart failure
por: Xu, Lingyu, et al.
Publicado: (2021)

The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
por: Hamid, Tariq, et al.
Publicado: (2020)

Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure
por: Reis, José Rosino de Araújo Rocha, et al.
Publicado: (2015)

The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure
por: Zhou, Shanshan, et al.
Publicado: (2014)

Novel Mechanistic Roles for Ankyrin-G in Cardiac Remodeling and Heart Failure
por: Makara, Michael A., et al.
Publicado: (2018)

Ginsenoside Rb1 improves cardiac function and remodeling in heart failure
por: Zheng, Xian, et al.
Publicado: (2017)

Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications
por: Chai, Ruoning, et al.
Publicado: (2022)

Cardiac reverse remodelling and health status in patients with chronic heart failure
por: Wang, Kaiming, et al.
Publicado: (2021)

Immunomodulators and Their Applications in Dentistry and Periodontics: A Comprehensive Review
por: Pahade, Abhishek, et al.
Publicado: (2023)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Kessler, Elise L., et al.
Publicado: (2020)

The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure
por: Song, Weihua, et al.
Publicado: (2015)

Genetic Dissection of Cardiac Remodeling in an Isoproterenol-Induced Heart Failure Mouse Model
por: Wang, Jessica Jen-Chu, et al.
Publicado: (2016)

Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?()
por: Gupta, Kartik, et al.
Publicado: (2019)

Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension
por: Prins, Kurt W., et al.
Publicado: (2020)

COVID-19 and immunomodulation treatment for women with reproductive failures
por: Kwak-Kim, Joanne, et al.
Publicado: (2020)

Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study
por: Yola, Ibrahim Musa, et al.
Publicado: (2021)

TNFR1 Contributes to Activation-Induced Cell Death of Pathological CD4(+) T Lymphocytes During Ischemic Heart Failure
por: Kumar, Vinay, et al.
Publicado: (2022)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gk1up6a01grmhoj50otughlgac